|
시장보고서
상품코드
1991423
심낭천자 시술 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Pericardiocentesis Procedures Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
심낭천자 시술 시장 규모는 2025년 13억 1,000만 달러에서 2026년부터 2034년까지 CAGR 5.87%로 성장하여 2034년에는 21억 9,000만 달러에 달할 것으로 예상됩니다.
세계 심낭천자 시술 시장은 심낭강에서 긴급한 체액 배출이 필요한 심혈관 합병증 사례가 증가함에 따라 꾸준히 성장하고 있습니다. 심막 천자는 심장 주위의 과도한 체액을 제거하고 압력을 감소시켜 정상적인 심장 기능을 회복시키기 위해 사용되는 의료 시술입니다. 고급 심장 치료에 대한 인식이 높아지고 병원의 응급 의료 서비스가 향상됨에 따라 임상 현장에서 이 시술의 이용이 증가하고 있습니다.
심장 질환, 감염성 질환, 암과 관련된 심낭액 저류 유병률 증가 등 여러 요인이 시장 성장을 주도하고 있습니다. 병원과 심장센터에서는 시술의 안전성과 정확성을 높이기 위해 심장초음파 검사, 초음파 가이드 등 첨단 영상 진단 기술을 도입하고 있습니다. 의료 인프라 확충과 심혈관 치료에 대한 투자 증가도 심낭천자 시술에 사용되는 전문 장비의 도입을 촉진하고 있습니다.
의료 기술이 심장 치료의 성과를 지속적으로 향상시키고 있기 때문에 시장의 향후 전망은 여전히 유망합니다. 최소침습적 기구의 개발과 카테터 설계의 개선으로 시술의 효율성과 환자의 안전성을 향상시킬 수 있습니다. 신흥국에서의 심장 의료 서비스 확대는 의료 서비스 제공자에게 더 많은 기회를 창출할 것입니다. 전 세계적으로 심혈관질환의 발병률이 지속적으로 증가함에 따라 심낭천자와 같은 효과적인 응급처치에 대한 수요가 확대될 것으로 예상됩니다.
목차
제1장 소개
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 심낭천자 시술 시장 : 시술 종류별
제5장 세계의 심낭천자 시술 시장 : 가이드법별
제6장 세계의 심낭천자 시술 시장 : 용도별
제7장 세계의 심낭천자 시술 시장 : 최종사용별
제8장 세계의 심낭천자 시술 시장 : 지역별
제9장 경쟁 구도
제10장 기업 개요
KSM 26.04.27The Pericardiocentesis Procedures Market size is expected to reach USD 2.19 Billion in 2034 from USD 1.31 Billion (2025) growing at a CAGR of 5.87% during 2026-2034.
The global pericardiocentesis procedures market has grown steadily due to increasing cases of cardiovascular complications that require emergency fluid drainage from the pericardial sac. Pericardiocentesis is a medical procedure used to remove excess fluid around the heart, helping relieve pressure and restore normal cardiac function. Rising awareness about advanced cardiac care and improvements in hospital emergency services have contributed to the increased use of this procedure in clinical settings.
Several factors are driving market growth, including the rising prevalence of heart diseases, infections, and cancer-related pericardial effusions. Hospitals and cardiac centers are increasingly adopting advanced imaging technologies such as echocardiography and ultrasound guidance to improve procedural safety and accuracy. Growing healthcare infrastructure and increasing investments in cardiovascular care are also encouraging the adoption of specialized equipment used during pericardiocentesis procedures.
The future outlook for the market remains promising as medical technologies continue to enhance cardiac treatment outcomes. The development of minimally invasive tools and improved catheter designs may increase procedural efficiency and patient safety. Expanding cardiac care services in emerging economies will likely create additional opportunities for healthcare providers. As cardiovascular disease rates continue to rise globally, demand for effective emergency procedures such as pericardiocentesis is expected to grow.
MARKET SEGMENTATION
By Procedure Type
- Emergency Pericardiocentesis
- Elective Pericardiocentesis
By Guidance Method
- Echocardiography-Guided
- Fluoroscopy-Guided
- CT-Guided
By Application
- Cardiac Tamponade
- Pericarditis
- Pericardial Effusion
By End Use
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
COMPANIES PROFILED
- Siemens Healthineers, Baxter International, Roche, GE Healthcare, Johnson and Johnson, Medtronic, Boston Scientific, Hologic, Terumo Corporation, Philips Healthcare, Cpachealth, Abbott Laboratories, Braun Melsungen, Stryker, Cardinal Health
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET: BY PROCEDURE TYPE 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Procedure Type
- 4.2. Emergency Pericardiocentesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Elective Pericardiocentesis Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET: BY GUIDANCE METHOD 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Guidance Method
- 5.2. Echocardiography-Guided Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Fluoroscopy-Guided Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. CT-Guided Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET: BY APPLICATION 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Application
- 6.2. Cardiac Tamponade Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Pericarditis Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Pericardial Effusion Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET: BY END USE 2022-2034 (USD MN)
- 7.1. Market Analysis, Insights and Forecast End Use
- 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.4. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL PERICARDIOCENTESIS PROCEDURES MARKET: BY REGION 2022-2034 (USD MN)
- 8.1. Regional Outlook
- 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Procedure Type
- 8.2.2 By Guidance Method
- 8.2.3 By Application
- 8.2.4 By End Use
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
- 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Procedure Type
- 8.3.2 By Guidance Method
- 8.3.3 By Application
- 8.3.4 By End Use
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
- 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Procedure Type
- 8.4.2 By Guidance Method
- 8.4.3 By Application
- 8.4.4 By End Use
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
- 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Procedure Type
- 8.5.2 By Guidance Method
- 8.5.3 By Application
- 8.5.4 By End Use
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 Rest of Latin America
- 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Procedure Type
- 8.6.2 By Guidance Method
- 8.6.3 By Application
- 8.6.4 By End Use
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa
Chapter 9. COMPETITIVE LANDSCAPE
- 9.1. Recent Developments
- 9.2. Company Categorization
- 9.3. Supply Chain & Channel Partners (based on availability)
- 9.4. Market Share & Positioning Analysis (based on availability)
- 9.5. Vendor Landscape (based on availability)
- 9.6. Strategy Mapping
Chapter 10. COMPANY PROFILES OF GLOBAL PERICARDIOCENTESIS PROCEDURES INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Company Profiles
- 10.2.1 Siemens Healthineers
- 10.2.2 Baxter International
- 10.2.3 Roche
- 10.2.4 GE Healthcare
- 10.2.5 Johnson And Johnson
- 10.2.6 Medtronic
- 10.2.7 Boston Scientific
- 10.2.8 Hologic
- 10.2.9 Terumo Corporation
- 10.2.10 Philips Healthcare
- 10.2.11 Cpachealth
- 10.2.12 Abbott Laboratories
- 10.2.13 Braun Melsungen
- 10.2.14 Stryker
- 10.2.15 Cardinal Health
